Cingulate Share Price

Cingulate Share Price

NASDAQ: CING | Micro Cap | Healthcare
$5.11
+$0.38 (8.03%) Last updated on 19 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Cingulate Stock Performance

Open
$4.92
Prev. Close
$4.73
Circuit Range
N/A
Day Range
$4.91 - $5.39
Year Range
$3.19 - $11.78
Volume
17,156
Average Traded
$5.16

Cingulate Share Price Today

As of 19 November 2026, Cingulate Inc.'s share price is $5.11. The stock opened at $4.92, compared to its previous close of $4.73. During today's trading session, Cingulate Inc.'s share price traded between $4.91 and $5.39, with an average price of $5.15. Over the past 52 weeks, the stock has recorded a high of $11.78 and a low of $3.19. In terms of performance, Cingulate Inc.'s share price has risen by 23.88% over the last six months and is up 37.55% on a year-on-year basis.

Cingulate Share Price Chart

Line chart of the Cingulate price trend over the selected period. The price rose overall, ranging from 4.91 to 5.42, ending at 5.09.
$4.91$5.39
L
Show Current Price
H

Cingulate Stock Fundamentals & Key Indicators

Market Cap
$25.83M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.95
Revenue (TTM)
$0.00
Return On Equity (TTM)
-140.54%
Profit Margin
N/A
Debt to Equity
0.16
Quarterly Earnings Growth YoY
-23.29%

Cingulate Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$6.27-$9.31-$5.87-$7.73
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-48.48%36.95%-31.69%

Cingulate Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$17.68-$23.53-$16.56-$22.45
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-33.09%29.62%-35.57%

Cingulate Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets3.072.22.913.54
Current Assets12.0112.660.587.87
Total Assets15.0714.863.4911.41
Non Current Liabilities2.252.440.140.51
Current Liabilities10.314.9710.237.01
Total Liabilities12.567.4110.367.52
Shareholders' Equity2.517.46-6.873.88

Cingulate Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-17.25-18.45-15.03-15.88
Investing-0.16-0.21-0.22-0.15
Financing16.1530.829.954.9

Corporate Actions

Split
Ex-date: 09 Aug 2024

Split
Ex-date: 30 Nov 2023

About Cingulate

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Cingulate Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$5.08
$5.09
+3.46%
Oct 2026
$4.80
$4.92
-0.61%
Sep 2026
$5.16
$4.95
-8.16%
Aug 2026
$4.87
$5.39
+12.76%
Jul 2026
$5.63
$4.78
-12.29%
Jun 2026
$3.29
$5.45
+32.12%
May 2026
$5.16
$4.13
-19.35%
Apr 2026
$6.38
$5.12
-16.90%
Mar 2026
$6.01
$6.16
-1.83%
Feb 2026
$5.87
$6.27
+9.62%
Jan 2026
$4.31
$5.72
+32.71%
Dec 2025
$3.65
$4.31
+16.02%

Cingulate Share Price FAQs